266 related articles for article (PubMed ID: 15690087)
21. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
[TBL] [Abstract][Full Text] [Related]
22. Pulsatility of growth hormone (GH) signalling in liver cells: role of the JAK-STAT5b pathway in GH action.
Choi HK; Waxman DJ
Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S1-8. PubMed ID: 10984246
[TBL] [Abstract][Full Text] [Related]
23. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation.
Miller ME; Michaylira CZ; Simmons JG; Ney DM; Dahly EM; Heath JK; Lund PK
Gastroenterology; 2004 Aug; 127(2):570-81. PubMed ID: 15300589
[TBL] [Abstract][Full Text] [Related]
24. GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.
Martinez CS; Piazza VG; Díaz ME; Boparai RK; Arum O; Ramírez MC; González L; Becú-Villalobos D; Bartke A; Turyn D; Miquet JG; Sotelo AI
J Mol Endocrinol; 2015 Apr; 54(2):171-84. PubMed ID: 25691498
[TBL] [Abstract][Full Text] [Related]
25. Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro.
Leong GM; Moverare S; Brce J; Doyle N; Sjögren K; Dahlman-Wright K; Gustafsson JA; Ho KK; Ohlsson C; Leung KC
Endocrinology; 2004 Dec; 145(12):5525-31. PubMed ID: 15319356
[TBL] [Abstract][Full Text] [Related]
26. Discrimination between signaling pathways in regulation of specific gene expression by insulin and growth hormone in hepatocytes.
Ribaux P; Gjinovci A; Sadowski HB; Iynedjian PB
Endocrinology; 2002 Oct; 143(10):3766-72. PubMed ID: 12239086
[TBL] [Abstract][Full Text] [Related]
27. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
[TBL] [Abstract][Full Text] [Related]
28. SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis.
Pass C; MacRae VE; Huesa C; Faisal Ahmed S; Farquharson C
J Bone Miner Res; 2012 May; 27(5):1055-66. PubMed ID: 22228213
[TBL] [Abstract][Full Text] [Related]
29. SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration.
Masuzaki R; Zhao S; Valerius MT; Tsugawa D; Oya Y; Ray KC; Karp SJ
J Biol Chem; 2016 Feb; 291(7):3346-58. PubMed ID: 26703468
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
31. Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins.
Ben-Yair L; Slaaby R; Herman A; Cohen Y; Biener E; Moran N; Yoshimura A; Whittaker J; De Meyts P; Herman B; Gertler A
Protein Expr Purif; 2002 Aug; 25(3):456-64. PubMed ID: 12182826
[TBL] [Abstract][Full Text] [Related]
32. Lack of Socs2 expression causes the high-growth phenotype in mice.
Horvat S; Medrano JF
Genomics; 2001 Mar; 72(2):209-12. PubMed ID: 11401434
[TBL] [Abstract][Full Text] [Related]
33. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
[TBL] [Abstract][Full Text] [Related]
34. Cytokine-inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice.
González L; Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2002 Feb; 143(2):386-94. PubMed ID: 11796490
[TBL] [Abstract][Full Text] [Related]
35. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
Yang HL; Sun C; Sun C; Qi RL
Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
[TBL] [Abstract][Full Text] [Related]
36. A designed cell-penetrating human SOCS2 protein suppresses GH-dependent cancer cell proliferation.
Miyamoto A; Masuhiro Y; Seki T; Hanazawa S; Shiba H
Biosci Biotechnol Biochem; 2019 Feb; 83(2):300-308. PubMed ID: 30343638
[TBL] [Abstract][Full Text] [Related]
37. Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2.
Ransome MI; Turnley AM
Neuroscience; 2005; 132(3):673-87. PubMed ID: 15837129
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone and SOCS2 regulation of neuronal differentiation: possible role in mental function.
Turnley AM
Pediatr Endocrinol Rev; 2005 Mar; 2(3):366-71. PubMed ID: 16429112
[TBL] [Abstract][Full Text] [Related]
40. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance.
Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D
J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
